Subject(s)
Extracorporeal Circulation , Cardiopulmonary Bypass/history , Cardiopulmonary Bypass/trends , Diffusion of Innovation , Extracorporeal Circulation/history , Extracorporeal Circulation/trends , Extracorporeal Membrane Oxygenation/history , Extracorporeal Membrane Oxygenation/trends , History, 20th Century , History, 21st Century , HumansSubject(s)
Cardiac Surgical Procedures/history , Extracorporeal Circulation/history , Heart Defects, Congenital/history , Cardiac Surgical Procedures/methods , Child, Preschool , Extracorporeal Circulation/methods , Female , Heart Defects, Congenital/surgery , History, 20th Century , Humans , Infant , Male , MinnesotaABSTRACT
Alexis Carrel and Charles Lindbergh were among the most famous international figures in the 20th century: Carrel, the surgeon-scientist who won a Nobel prize as a young surgeon, and Lindbergh, the aviator-engineer who pioneered aviation and promoted commercial flight throughout his life. Surprisingly, these two amazing individuals came together to collaborate on the early development of extracorporeal circulation. Their work was interrupted by the onset of World War II, which destroyed one of them and nearly destroyed the other.
Subject(s)
Aviation/history , Cardiovascular Surgical Procedures/history , Cooperative Behavior , Extracorporeal Circulation/history , Famous Persons , France , History, 19th Century , History, 20th Century , Humans , National Socialism/history , Nobel Prize , Surgeons/history , United StatesSubject(s)
Biomedical Research , Extracorporeal Circulation , Heart-Lung Machine , Biomedical Research/economics , Biomedical Research/history , Biomedical Research/methods , Extracorporeal Circulation/economics , Extracorporeal Circulation/history , Extracorporeal Circulation/methods , Heart-Lung Machine/economics , Heart-Lung Machine/history , History, 20th Century , History, 21st Century , Humans , Time FactorsSubject(s)
Heart Defects, Congenital , Extracorporeal Circulation/history , Extracorporeal Circulation/methods , France , Heart Defects, Congenital/history , Heart Defects, Congenital/surgery , History, 20th Century , History, 21st Century , Humans , Pediatrics/history , Pediatrics/methods , PhysiciansABSTRACT
The world's first implantable total artificial heart was designed by Vladimir Demikhov as a fourth year biology student in Voronezh, Soviet Union, in 1937. As a prototype of his device, Demikhov must have used an apparatus for extracorporeal blood circulation invented by Sergei Bryukhonenko of Moscow. The device was the size of a dog's native heart and consisted of two diaphragm pumps brought into motion by an electric motor. A dog with an implanted device lived for 2.5 hours. In addition to having the prototype, the preconditions for Demikhov's artificial heart creation were his manual dexterity, expertise in animal physiology, and his mechanistic worldview.
Subject(s)
Extracorporeal Circulation/history , Heart, Artificial/history , Animals , Dogs , History, 20th Century , USSRSubject(s)
Cardiology/history , Extracorporeal Circulation/history , History, 20th Century , History, 21st Century , Humans , Male , TexasSubject(s)
Extracorporeal Circulation/history , Female , History, 20th Century , History, 21st Century , HumansABSTRACT
Extracorporeal organ support in patients with dysfunction of vital organs like the kidney, heart, and liver has proven helpful in bridging the patients to recovery or more definitive therapy. Mechanical ventilation in patients with respiratory failure, although indispensable, has been associated with worsening injury to the lungs, termed ventilator-induced lung injury. Application of lung-protective ventilation strategies are limited by inevitable hypercapnia and hypercapnic acidosis. Various alternative extracorporeal strategies, proposed more than 30 years ago, to combat hypercapnia are now more readily available. In particular, the venovenous approach to effective carbon dioxide removal, which involves minimal invasiveness comparable to renal replacement therapy, appears to be very promising. The clinical applications of these extracorporeal carbon dioxide removal therapies may extend beyond just lung protection in ventilated patients. This article summarizes the rationale, technology and clinical application of various extracorporeal lung assist techniques available for clinical use, and some of the future perspectives in the field.
Subject(s)
Carbon Dioxide/blood , Carbon Dioxide/isolation & purification , Extracorporeal Circulation/methods , Catheters , Equipment Design , Extracorporeal Circulation/history , Extracorporeal Circulation/instrumentation , Extracorporeal Membrane Oxygenation/history , Extracorporeal Membrane Oxygenation/instrumentation , Extracorporeal Membrane Oxygenation/methods , History, 20th Century , History, 21st Century , Humans , Lung/pathology , Respiratory Insufficiency/therapyABSTRACT
Cardiopulmonary bypass (CPB) is a standard procedure in cardiac surgery; however, apart from its therapeutic options a CPB might also initiate systemic and organ-specific complications, such as heart failure, renal and pulmonary dysfunction, impaired coagulation as well as neurological and cognitive dysfunction. The immunological response to the extracorporeal circulation generates systemic inflammation which often meets the definition of systemic inflammatory response syndrome (SIRS). The main inducers of SIRS are contact of blood with the artificial surfaces of the CPB, mechanical stress which affects the blood components and the extensive surgical trauma. Hence, a number of technical and surgical developments aim at reduction of the inflammatory response caused by the CPB. By reason of surgical demands, the majority of cardiothoracic procedures still depend on the use of CPB; however, there is an on-going development of new techniques trying to reduce the surgical trauma and the negative consequences of CPB. Here, minimized systems with biocompatible surfaces have been shown to be effective in attenuating the inflammatory response to CPB. Alternative procedures such as off-pump surgery may help to avoid CPB-associated complications but due to specific limitations will not replace conventional bypass surgery.